Psychoses, Substance-Induced
"Psychoses, Substance-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
Descriptor ID |
D011605
|
MeSH Number(s) |
C25.723.809 C25.775.746 F03.700.675.600 F03.900.746
|
Concept/Terms |
Psychoses, Substance-Induced- Psychoses, Substance-Induced
- Psychoses, Substance Induced
- Substance-Induced Psychoses
- Substance Induced Psychoses
- Toxic Psychoses
- Psychoses, Toxic
|
Below are MeSH descriptors whose meaning is more general than "Psychoses, Substance-Induced".
Below are MeSH descriptors whose meaning is more specific than "Psychoses, Substance-Induced".
This graph shows the total number of publications written about "Psychoses, Substance-Induced" by people in this website by year, and whether "Psychoses, Substance-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2017 | 4 | 2 | 6 |
2018 | 2 | 2 | 4 |
2019 | 1 | 1 | 2 |
2020 | 1 | 1 | 2 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Psychoses, Substance-Induced" by people in Profiles.
-
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). 2021 07 01; 60(7):3222-3234.
-
Cannabis withdrawal induced brief psychotic disorder: a case study during the national lockdown secondary to the COVID-19 pandemic. J Addict Dis. 2021 Oct-Dec; 39(4):579-584.
-
Acetyl-l-Carnitine and New-Onset Psychosis During the COVID-19 Pandemic. Prim Care Companion CNS Disord. 2020 12 03; 22(6).
-
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study. Drug Saf. 2020 12; 43(12):1315-1322.
-
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clin Toxicol (Phila). 2021 01; 59(1):12-23.
-
Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients. Indian J Pharmacol. 2020 May-Jun; 52(3):229-231.
-
Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae. Psychosomatics. 2020 Nov - Dec; 61(6):597-606.
-
Psychiatric side effects of chloroquine in COVID-19 patients: two case reports. Pan Afr Med J. 2020; 35(Suppl 2):83.
-
Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19. Biol Psychiatry. 2021 02 01; 89(3):e9.
-
Schizophr Res. 2019 04; 206:1.